Efficacy and safety of intravenous itraconazole as empirical antifungal therapy for persistent fever in neutropenic patients with hematological malignancies in Japan-Reference-Cited by-同舟云学术

Efficacy and safety of intravenous itraconazole as empirical antifungal therapy for persistent fever in neutropenic patients with hematological malignancies in Japan

Published:2009-05-19 Issue:5 Volume:89 Page:649-655
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Ohta Kensuke,Nishiki Kosaka Saori,Nakao Yoshitaka,Kumura Takeo,Hagihara Kiyomichi,Sakamoto Erina,Okamoto Shuichiro,Hirose Asao,Aoyama Yasutaka,Yamamura Ryousuke,Hayashi Yoshiki,Umemoto Yukari,Terada Yoshiki,Takeoka Yasunobu,Nakane Takahiko,Koh Hideo,Hino Masayuki

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://link.springer.com/content/pdf/10.1007/s12185-009-0316-3.pdf

Reference19 articles.

1. Kume H, Yamazaki T, Abe M, Tanuma H, Okudaira M, Okayasu I. Epidemiology of visceral mycoses in patients with leukemia and MDS—Analysis of the data in annual of pathological autopsy cases in Japan in 1989, 1993, 1997 and 2001-. Jpn J Med Mycol. 2006;47:15–24.

2. Wingard JR. Importance of Candida species other than C. albicans as pathogens in oncology patients. Clin Infect Dis. 1995;20:115–25.

3. Committee making guideline of systemic fungal infections editors: guidelines for diagnosis and treatment and of systemic fungal infections 2007. Tokyo: Kyowakikaku; 2007.

4. EORTC international antimicrobial therapy cooperative group: empiric antifungal therapy in febrile granulocytopenic patients. Am J Med. 1989;86:668–72. doi: 10.1016/0002-9343(89)90441-5 .

5. Booraerts M, Winston DJ, Bow EJ, Garber G, Reboli AC, Schwarer AP, et al. Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy A randomized, controlled trial. Ann Intern Med. 2001;135:412–22.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A multicenter phase 2 study of empirical low-dose liposomal amphotericin B in patients with refractory febrile neutropenia;International Journal of Hematology;2016-09-30

2. Association of systolic blood pressure drop with intravenous administration of itraconazole in children with hemato-oncologic disease;Drug Design, Development and Therapy;2015-12

3. Success Rate and Risk Factors for Failure of Empirical Antifungal Therapy with Itraconazole in Patients with Hematological Malignancies: A Multicenter, Prospective, Open-Label, Observational Study in Korea;Journal of Korean Medical Science;2014

4. Clinical Outcomes and Prognostic Factors of Empirical Antifungal Therapy with Itraconazole in the Patients with Hematological Malignancies: A Prospective Multicenter Observational Study in Korea;Yonsei Medical Journal;2014

5. The relationship between the success rate of empirical antifungal therapy with intravenous itraconazole and clinical parameters, including plasma levels of itraconazole, in immunocompromised patients receiving itraconazole oral solution as prophylaxis: a multicenter, prospective, open-label, observational study in Korea;Annals of Hematology;2013-06-27